Stock listing

NASDAQ:IMMU Immunomedics Inc Stock

Follow Immunomedics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:IMMU

$87.86 USD

Close on Oct 22, 2020 · No longer trades

Jun 24, 1985 to last close +2,097% · monthly closes, Jun 24, 1985 – Oct 22, 2020
Lowest – highest close
$0.84 – $87.86 USDSince Jun 24, 1985 · lowest Mar 5, 2009 · highest Oct 22, 2020

Delisted NASDAQ:IMMU no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:IMMU
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Immunomedics Inc on 6ix

Decks
8 decks · latest Aug 5, 2020

Decks

DeckKindSlidesDate
Q2 2020 Earnings PresentationEarnings23 slidesAug 5, 2020
Proxy Contest (February 2017)Proxy contest23 slidesFeb 10, 2017
Proxy Contest (January 2017)Proxy contest19 slidesJan 30, 2017
Proxy Contest (January 2017)Proxy contest29 slidesJan 27, 2017
Proxy Contest (January 2017)Proxy contest38 slidesJan 26, 2017
Investor Day (January 2017)Investor day122 slidesJan 18, 2017
Proxy Contest (January 2017)Proxy contest28 slidesJan 18, 2017
Proxy Contest (December 2016)Proxy contest24 slidesDec 14, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert Azelby
Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Aduro Biotech Inc (Director · Apr 10, 2023 – Aug 11, 2023 · Past); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Alder BioPharmaceuticals Inc (President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past)
Director · Feb 26, 2020 – Oct 23, 2020 · Past
Peter P Pfreundschuh
Other companies: Y mAbs Therapeutics (EVP, CFO and Treasurer · Since at least Jun 28, 2024); Voyager Therapeutics, Inc. (Chief Financial Officer · Sep 19, 2022 – Feb 21, 2024 · Past); Korro Bio, Inc. (Chief Financial Officer · Dec 1, 2020 – Feb 18, 2022 · Past); UroGen Pharma Ltd. (Chief Financial Officer · Jan 1, 2019 – Oct 15, 2020 · Past); Sucampo Pharmaceuticals Inc (CFO · Mar 20, 2017 – Feb 13, 2018 · Past)
Chief Financial Officer · Aug 20, 2015 – Aug 20, 2015 · Past
Scott A Canute
Other companies: Oncorus Inc (Director · Dec 11, 2020 – Jun 23, 2022 · Past); Flexion Therapeutics Inc (Director · Jun 20, 2018 – Nov 19, 2021 · Past); Akebia Therapeutics, Inc. (Director · Jun 14, 2018 – Jun 6, 2019 · Past); Protara Therapeutics, Inc. (Director · Jun 8, 2018 – Jun 8, 2018 · Past); Outlook Therapeutics, Inc. (Director · Oct 26, 2017 – Oct 26, 2017 · Past)
Director · Apr 2, 2018 – Oct 23, 2020 · Past
Behzad Aghazadeh
Other companies: Scribe Therapeutics Inc. (Director · Since at least Jul 23, 2026); Whitehawk Therapeutics, Inc. (Director · Since at least Aug 26, 2021)
Director · Oct 23, 2020 – Oct 23, 2020 · Past
Bryan Ball
Other companies: Whitehawk Therapeutics, Inc. (Chief Technical Operations Officer · Since at least Apr 23, 2024); Intercept Pharmaceuticals Inc (Chief Qual. Officer & SVP Ops. · Jan 11, 2021 – Jul 11, 2022 · Past)
Chief Quality Officer · Mar 5, 2019 – Oct 23, 2020 · Past
Lorettta M Itri
Other companies: Whitehawk Therapeutics, Inc. (CHIEF MEDICAL OFFICER · Oct 21, 2021 – Mar 1, 2024 · Past)
Chief Medical Officer · Oct 23, 2020 – Oct 23, 2020 · Past
Morris Rosenberg
Other companies: Seagen Inc (EVP, Process Sciences · Mar 13, 2012 – Jun 12, 2012 · Past)
Chief Technology Officer · Apr 12, 2018 – Sep 6, 2019 · Past
William Fricker
Other companies: NRX Pharmaceuticals, Inc. (CFO & Treasurer · May 24, 2021 – May 24, 2021 · Past)
Principal Accounting Officer · Aug 23, 2018 – Oct 23, 2020 · Past

Open People

Log in to ask 6ix AI your own questions about Immunomedics Inc.